When.com Web Search

  1. Ads

    related to: pioglitazone therapy

Search results

  1. Results From The WOW.Com Content Network
  2. Pioglitazone - Wikipedia

    en.wikipedia.org/wiki/Pioglitazone

    Pioglitazone, sold under the brand name Actos among others, is an anti-diabetic medication used to treat type 2 diabetes. [3] It may be used with metformin , a sulfonylurea , or insulin . [ 3 ] [ 4 ] Use is recommended together with exercise and diet. [ 4 ]

  3. Pioglitazone/metformin - Wikipedia

    en.wikipedia.org/wiki/Pioglitazone/metformin

    Pioglitazone/metformin is contraindicated in people with known hypersensitivity to any components of this combination. These combination also contraindicated in renal disease which may also result from conditions, e.g., acute myocardial infarction , sepsis , acute or chronic metabolic acidosis , including diabetic ketoacidosis , with or without ...

  4. Pioglitazone/glimepiride - Wikipedia

    en.wikipedia.org/wiki/Pioglitazone/glimepiride

    Pioglitazone makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces. [1] Glimepiride is a sulphonylurea: it stimulates the pancreas to produce more insulin. [ 1 ]

  5. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Thiazolidinediones (Tzd) – pioglitazone, Actos generic; Alpha-glucosidase inhibitors – Acarbose; Meglitinides – nateglinide; Combination of sulfonylureas plus metformin – known by generic names of the two drugs; No generics are available for dipeptidyl peptidase-4 inhibitors (Onglyza), the glifozins, the incretins and various combinations.

  6. Fatty Liver Disease: What Men Need to Know - AOL

    www.aol.com/fatty-liver-disease-men-know...

    Pioglitazone. In March 2024, the U.S. Food and Drug Administration (FDA) approved resmetirom — sold under the brand name Rezdiffra® — for people with NASH and moderate to advanced liver scarring.

  7. Thiazolidinedione - Wikipedia

    en.wikipedia.org/wiki/Thiazolidinedione

    Because of this, the FDA recommends two to three month checks of liver enzymes for the first year of thiazolidinedione therapy to check for this rare but potentially catastrophic complication. To date, 2008, the newer thiazolidinediones, rosiglitazone and pioglitazone have been free of this problem. [citation needed]